Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
R. Rathnasinghe, M. Salvatore, H. Zheng, S. Jangra, T. Kehrer, I. Mena, M. Schotsaert, T. Muster, P. Palese, A. Garcia-Sastre
This study shows that a live attenuated influenza virus vaccine lacking NS1 provides broad protection against respiratory viruses including SARS-CoV-2 by inducing both innate and adaptive immune responses.
bioRxiv · Apr 28, 2021Microbiology